Pharmafile Logo

Market Study Report

Market Study Report is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

Market Study Report, 4 North Main Street, Selbyville, Delaware, 19975, USA
1-302-273-0910

 Latest Content from PMHub 

Medscape Oncology: Delivering Impact at ASH

You can read more information on Medscape Oncology at ASH here, or please reach out to Chris Carey or Steve Dunn who can tell you more about how Medscape can help to...

Medscape Oncology: Delivering Impact at ASH

Medscape Oncology was on-site in New Orleans at ASH 2022. During the 4-day conference, Medscape Oncology hosted educational symposia, interacted with clinicians at our booth, and worked with leading faculty...

Lianne’s Story – Supporting Deaf People With Their Mental Health

Take a look at how we helped a member of our team to achieve her goal of providing more support to the Deaf community

Introduction to Origins

In this short video Mark Corbett, Chief Innovation Officer at Resonant Group, gives a brief introduction to Origins, the patient focused specialist agency.If you'd like to know more, visit the...

Streamlining Healthcare Delivery Through Digital Care Journeys

Dr. Joshua Liu, Co-founder & CEO of SeamlessMD, explores how technology and “Digital Care Journeys” can help hospitals reduce the surgical backlog for high-volume procedures like hip and knee replacements,...

Medscape Education: Rare Diseases PAH

Today is Rare Disease Day, February 28.Hear from Helen as she describes in her own words what it’s like to live with PAH, and her perspective as a patient.  To learn...

Medscape Education and M4RD: Together Caring for Rare Disease

We are excited to finally share our news-style video ' ', developed in partnership with Medics 4 Rare Diseases (M4RD) and produced by Genetic Alliance UK and ITN Business.For more information on...

The Need for and Impact of Rare Disease Education

Press Releases | February 28, 2023 | Medscape Education

Physicians are often told that when they hear hoofbeats, think horses, not zebras — to look for the most common cause of a patient’s symptoms first. While this advice may...

Pharmaceutical companies reduce own greenhouse gas emissions, but action on supply chains needed

Press Releases | February 27, 2023 | Oxford PharmaGenesis

DPhil student, Dr Amy Booth (University of Oxford) and Oxford PharmaGenesis CEO, Dr Chris Winchester, have co-authored a new study published in the International Journal of Environmental Research and Public...

Kate Shaw comments the appointment of an independent review on clinical trials in the UK.

Press Releases | February 27, 2023 | Innovative Trials

The news comes after a report by the Association of the British Pharmaceutical Industry (ABPI) highlighted a 44% decline in industry clinical trials in the UK over the last five...